Cancer immunoediting: from immunosurveillance to tumor escape (original) (raw)

• Ehrlich, P. Ueber den jetzigen stand der Karzinomforschung. Ned. Tijdschr. Geneeskd. 5, 273–290 (1909).
  Google Scholar
• Silverstein, A.M. A History of Immunology (Academic, San Diego, CA, 1989).
• Old, L.J. & Boyse, E.A. Immunology of experimental tumors. Annu. Rev. Med. 15, 167–186 (1964).
  Article CAS PubMed Google Scholar
• Klein, G. Tumor antigens. Annu. Rev. Microbiol. 20, 223–252 (1966).
  Article CAS PubMed Google Scholar
• Burnet, F.M. Cancer—a biological approach. Brit. Med. J. 1, 841–847 (1957).
  Article CAS PubMed PubMed Central Google Scholar
• Thomas, L. in Cellular and Humoral Aspects of the Hypersensitive States (ed. Lawrence, H. S.) 529–532 (Hoeber-Harper, New York, 1959).
  Google Scholar
• Burnet, F.M. The concept of immunological surveillance. Prog. Exp. Tumor Res. 13, 1–27 (1970).
  Article CAS PubMed Google Scholar
• Burnet, F.M. Immunological factors in the process of carcinogenesis. Br. Med. Bull. 20, 154–158 (1964).
  Article CAS PubMed Google Scholar
• Kaplan, H.S. Role of immunologic disturbance in human oncogenesis: some facts and fancies. Br. J. Cancer 25, 620–634 (1971).
  Article CAS PubMed PubMed Central Google Scholar
• Stutman, O. Immunodepression and malignancy. Adv. Cancer Res. 22, 261–422 (1975).
  Article CAS PubMed Google Scholar
• Grant, G.A. & Miller, J.F. Effect of neonatal thymectomy on the induction of sarcomata in C57BL mice. Nature 205, 1124–1125 (1965).
  Article CAS PubMed Google Scholar
• Nishizuka, Y., Nakakuki, K. & Usui, M. Enhancing effect of thymectomy on hepatotumorigenesis in Swiss mice following neonatal injection of 20-methylcholanthrene. Nature 205, 1236–1238 (1965).
  Article Google Scholar
• Trainin, N., Linker-Israeli, M., Small, M. & Boiato-Chen, L. Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan. Int. J. Cancer 2, 326–336 (1967).
  Article CAS PubMed Google Scholar
• Burstein, N.A. & Law, L.W. Neonatal thymectomy and non-viral mammary tumours in mice. Nature 231, 450–452 (1971).
  Article CAS PubMed Google Scholar
• Sanford, B.H., Kohn, H.I., Daly, J.J. & Soo, S.F. Long-term spontaneous tumor incidence in neonatally thymectomized mice. J. Immunol. 110, 1437–1439 (1973).
  CAS PubMed Google Scholar
• Klein, G. Immunological surveillance against neoplasia. Harvey Lect., 71–102 (1973).
• Flanagan, S.P. 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet. Res. 8, 295–309 (1966).
  Article CAS PubMed Google Scholar
• Pantelouris, E.M. Absence of thymus in a mouse mutant. Nature 217, 370–371 (1968).
  Article CAS PubMed Google Scholar
• Stutman, O. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183, 534–536 (1974).
  Article CAS PubMed Google Scholar
• Stutman, O. in Proceedings of the International Workshop on Nude Mice Vol. 1 (eds. Rygaard, J. & Poulsen, C.) 257–264 (Gustav Fischer, Stuttgart 1973).
  Google Scholar
• Stutman, O. Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous and heterozygous matings and effect of age and carcinogen dose. J. Natl. Cancer Inst. 2, 353–358 (1979).
  Google Scholar
• Outzen, H.C., Custer, R.P., Eaton, G.J. & Prehn, R.T. Spontaneous and induced tumor incidence in germfree “nude” mice. J. Reticuloendothel. Soc. 17, 1–9 (1975).
  CAS PubMed Google Scholar
• Stutman, O. in The Nude Mouse in Experimental and Clinical Research (eds. Fogh, J. & Giovanella, B. C.) 411–435 (Academic, New York, 1978).
  Google Scholar
• Rygaard, J. & Povlsen, C.O. Is immunological surveillance not a cell-mediated immune function? Transplantation 17, 135–136 (1974).
  Article CAS PubMed Google Scholar
• Rygaard, J. & Povlsen, C.O. The mouse mutant nude does not develop spontaneous tumours. An argument against immunological surveillance. Acta Pathol. Microbiol. Scand. [B] Microbiol. Immunol. 82, 99–106 (1974).
  CAS Google Scholar
• Maleckar, J.R. & Sherman, L.A. The composition of the T cell receptor repertoire in nude mice. J. Immunol. 138, 3873–3876 (1987).
  CAS PubMed Google Scholar
• Ikehara, S., Pahwa, R.N., Fernandes, G., Hansen, C.T. & Good, R.A. Functional T cells in athymic nude mice. Proc. Natl. Acad. Sci. USA 81, 886–888 (1984).
  Article CAS PubMed PubMed Central Google Scholar
• Hunig, T. T-cell function and specificity in athymic mice. Immunol. Today 4, 84–87 (1983).
  Article CAS PubMed Google Scholar
• Heidelberger, C. Chemical carcinogenesis. Annu. Rev. Biochem. 44, 79–121 (1975).
  Article CAS PubMed Google Scholar
• Kouri, R.E. & Nebert, D.W. in Origins of Human Cancer (eds. Hiatt, H. H., Watson, J. D. & Winsten, J. A.) 811–835 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1977).
  Google Scholar
• Hayday, A.C. γδ cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975–1026 (2000).
  Article CAS PubMed Google Scholar
• Prehn, R.T. Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia? J. Reticuloenothel. Soc. 10, 1–16 (1970).
  Google Scholar
• Thomas, L. On immunosurveillance in human cancer. Yale J. Biol. Med. 55, 329–333 (1982).
  CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Herberman, R.B. & Holden, H.T. Natural cell-mediated immunity. Adv. Cancer Res. 27, 305–377 (1978).
  Article CAS PubMed Google Scholar
• Engel, A.M. et al. Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression. APMIS 104, 629–639 (1996).
  Article CAS PubMed Google Scholar
• Engel, A.M., Svane, I.M., Rygaard, J. & Werdelin, O. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand. J. Immunol. 45, 463–470 (1997).
  Article CAS PubMed Google Scholar
• Schuler, W. et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46, 963–972 (1986).
  Article CAS PubMed Google Scholar
• Featherstone, C. & Jackson, S.P. DNA double-strand break repair. Curr. Biol. 9, R759–R761 (1999).
  Article CAS PubMed Google Scholar
• Dighe, A.S., Richards, E., Old, L.J. & Schreiber, R.D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN-γ receptors. Immunity 1, 447–456 (1994).
  Article CAS PubMed Google Scholar
• Kaplan, D.H. et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556–7561 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Street, S.E., Cretney, E. & Smyth, M.J. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97, 192–197 (2001).
  Article CAS PubMed Google Scholar
• Street, S.E., Trapani, J.A., MacGregor, D. & Smyth, M.J. Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med. 196, 129–134 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Russell, J.H. & Ley, T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20, 323–370 (2002).
  Article CAS PubMed Google Scholar
• van den Broek, M.F. et al. Decreased tumor surveillance in perforin-deficient mice. J.Exp.Med. 184, 1781–1790 (1996).
  Article CAS PubMed Google Scholar
• Smyth, M.J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661–668 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Smyth, M.J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755–760 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992).
  Article CAS PubMed Google Scholar
• Shankaran, V. et al. IFN-γ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107–1111 (2001).
  Article CAS PubMed Google Scholar
• Girardi, M. et al. Regulation of cutaneous malignancy by γδ T cells. Science 294, 605–609 (2001).
  Article CAS PubMed Google Scholar
• Penn, I. Malignant Tumors in Organ Transplant Recipients (Springer-Verlag, New York, 1970).
• Gatti, R.A. & Good, R.A. Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28, 89–98 (1971).
  Article CAS PubMed Google Scholar
• Penn, I. Posttransplant malignancies. Transplant Proc. 31, 1260–1262 (1999).
  Article CAS PubMed Google Scholar
• Birkeland, S.A. et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int. J. Cancer 60, 183–189 (1995).
  Article CAS PubMed Google Scholar
• Sheil, A.G.R. in Kidney Transplantation (ed. Morris, P. J.) 558–570 (Saunders, Philadelphia, 2001).
  Google Scholar
• Boshoff, C. & Weiss, R. AIDS-related malignancies. Nature Rev. Cancer 2, 373–382 (2002).
  Article CAS Google Scholar
• Hoover, R.N. in Origins of Human Cancer (eds. Hiatt, H. H., Watson, J. D. & Winsten, J. A.) 369–379 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1977).
  Google Scholar
• Sheil, A.G. Cancer after transplantation. World J. Surg. 10, 389–396 (1986).
  Article CAS PubMed Google Scholar
• Penn, I. Malignant melanoma in organ allograft recipients. Transplantation 61, 274–278 (1996).
  Article CAS PubMed Google Scholar
• Penn, I. Sarcomas in organ allograft recipients. Transplantation 60, 1485–1491 (1995).
  Article CAS PubMed Google Scholar
• Pham, S.M. et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann. Thorac. Surg. 60, 1623–1626 (1995).
  Article CAS PubMed Google Scholar
• Clark, W.H. Jr et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81, 1893–1904 (1989).
  Article PubMed Google Scholar
• Clemente, C.G. et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77, 1303–1310 (1996).
  Article CAS PubMed Google Scholar
• Mihm, M.C. Jr, Clemente, C.G. & Cascinelli, N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab. Invest. 74, 43–47 (1996).
  PubMed Google Scholar
• Rilke, F. et al. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int. J. Cancer 49, 44–49 (1991).
  Article CAS PubMed Google Scholar
• Lipponen, P.K., Eskelinen, M.J., Jauhiainen, K., Harju, E. & Terho, R. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur. J. Cancer 29A, 69–75 (1992).
  CAS PubMed Google Scholar
• Nacopoulou, L., Azaris, P., Papacharalampous, N. & Davaris, P. Prognostic significance of histologic host response in cancer of the large bowel. Cancer 47, 930–936 (1981).
  Article CAS PubMed Google Scholar
• Naito, Y. et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58, 3491–3494 (1998).
  CAS PubMed Google Scholar
• Epstein, N.A. & Fatti, L.P. Prostatic carcinoma: some morphological features affecting prognosis. Cancer 37, 2455–2465 (1976).
  Article CAS PubMed Google Scholar
• Deligdisch, L., Jacobs, A.J. & Cohen, C.J. Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response. Am. J. Obstet. Gynecol. 144, 885–889 (1982).
  Article CAS PubMed Google Scholar
• Jass, J.R. Lymphocytic infiltration and survival in rectal cancer. J. Clin. Pathol. 39, 585–589 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Palma, L., Di Lorenzo, N. & Guidetti, B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J. Neurosurg. 49, 854–861 (1978).
  Article CAS PubMed Google Scholar
• Uyttenhove, C., Van Snick, J. & Boon, T. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J. Exp. Med. 152, 1175–1183 (1980).
  Article CAS PubMed Google Scholar
• Urban, J.L., Holland, J.M., Kripke, M.L. & Schreiber, H. Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation. J. Exp. Med. 156, 1025–1041 (1982).
  Article CAS PubMed Google Scholar
• Svane, I.M. et al. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice. Eur. J. Immunol. 26, 1844–1850 (1996).
  Article CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
  Article CAS PubMed Google Scholar
• Smyth, M.J., Godfrey, D.I. & Trapani, J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunol. 2, 293–299 (2001).
  Article CAS Google Scholar
• Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
  Article CAS PubMed Google Scholar
• Yokoyama, W.M. Now you see it, now you don't! Nature Immunol. 1, 95–97 (2000).
  Article CAS Google Scholar
• Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721–727 (2000).
  Article CAS PubMed Google Scholar
• Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165–171 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Bromberg, J.F., Horvath, C.M., Wen, Z., Schreiber, R.D. & Darnell, J.E. Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA 93, 7673–7678 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Kumar, A., Commane, M., Flickinger, T.W., Horvath, C.M. & Stark, G.R. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278, 1630–1632 (1997).
  Article CAS PubMed Google Scholar
• Luster, A.D. & Ravetch, J.V. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166, 1084–1097 (1987).
  Article CAS PubMed Google Scholar
• Liao, F. et al. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182, 1301–1314 (1995).
  Article CAS PubMed Google Scholar
• Cole, K.E. et al. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009–2021 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Luster, A.D. & Leder, P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178, 1057–1065 (1993).
  Article CAS PubMed Google Scholar
• Sgadari, C., Angiolillo, A.L. & Tosato, G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87, 3877–3882 (1996).
  Article CAS PubMed Google Scholar
• Coughlin, C.M. et al. Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity 9, 25–34 (1998).
  Article CAS PubMed Google Scholar
• Qin, Z. & Blankenstein, T. CD4+ T cell–mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN-γ receptor expression by nonhematopoietic cells. Immunity 12, 677–686 (2000).
  Article CAS PubMed Google Scholar
• Bancroft, G.J., Schreiber, R.D. & Unanue, E.R. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124, 5–24 (1991).
  Article CAS PubMed Google Scholar
• Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251–276 (1995).
  Article CAS PubMed Google Scholar
• Ikeda, H., Old, L.J. & Schreiber, R.D. The roles of IFN-γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13, 95–109 (2002).
  Article CAS PubMed Google Scholar
• Takeda, K. et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195, 161–169 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Pardoll, D.M. Spinning molecular immunology into successful immunotherapy. Nature Rev. Immunol. 2, 227–238 (2002).
  Article CAS Google Scholar
• Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327–333 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343–351 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335–341 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Smyth, M.J., Crowe, N.Y. & Godfrey, D.I. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13, 459–463 (2001).
  Article CAS PubMed Google Scholar
• Noguchi, Y., Jungbluth, A., Richards, E. & Old, L.J. Effect of interleukin 12 on tumor induction by 3-methylcholanthrene. Proc. Natl. Acad. Sci. USA 93, 11798–11801 (1996).
  Article CAS PubMed PubMed Central Google Scholar